Landscapes / Companies
Shanghai Simnova Biotechnology Co.,Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Drugs
2
in active trials · 4 in all
Trials
2 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
CAR-NK-CD19 Cellsnot checked |
— |
Phase 1 | 31 Jan 2027Phase 1 trial completes | ||
| Next date | 31 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Lupus Erythematosis | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Recurrent Glioblastoma Multiforme (GBM) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021